• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Novartis slapped with $49m fine over kickbacks

April 27, 2017 By Sarah Faulkner

NovartisSouth Korea regulators said today that it fined Swiss drugmaker Novartis (NYSE:NVS) $48.8 million for offering doctors kickbacks in exchange for recommending the company’s drugs to patients.

The Ministry of Health and Welfare also decided to suspend insurance coverage of 9 variations of 2 drugs, including the Alzheimer’s drug Exelon, for 6 months, according to Reuters.

The ministry is slated to make a final decision next month, after it reviews the drugmaker’s response to its preliminary decision.

Novartis Korea told the news outlet that it acknowledged the ministry’s decision.

“We expect the Ministry of Health and Welfare to make a final decision by the end of May and understand there may be a grace period before the effective date of up to 3 months,” the company told Reuters.

In March, Korea’s food and drug safety ministry slapped Novartis Korea with a fine and temporarily barred sales of certain drugs.

A group of former and current Novartis employees in South Korea were indicted last year regarding illegal practices to boost sales. Trials for the 6 employees are under way.

Material from Reuters was used in this report. 

Filed Under: Featured, Legal News, Pharmaceuticals, Wall Street Beat Tagged With: Novartis

IN CASE YOU MISSED IT

  • Medtronic enrolls first patient in study for Onyx liquid embolic system
  • BD issues voluntary recall on certain Alaris infusion pump modules
  • Sequel Med Tech expects full twiist launch in the fall
  • Insulet hires new chief HR officer from J&J
  • Breakthrough T1D, Mattel debut Barbie doll with type 1 diabetes

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS